What is MBIO's earnings growth forecast for 2025-2025?
(NASDAQ: MBIO) Mustang Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Mustang Bio's earnings in 2025 is -$2,335,000.
In 2025, MBIO is forecast to generate -$130,288,685 in earnings, with the lowest earnings forecast at -$125,179,325 and the highest earnings forecast at -$134,120,705.
What is MBIO's revenue growth forecast for 2025-2025?
(NASDAQ: MBIO) Mustang Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Mustang Bio's revenue in 2025 is $0.
In 2025, MBIO is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.
What is MBIO's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: MBIO) forecast ROA is -672.94%, which is lower than the forecast US Biotechnology industry average of 7.96%.
What is MBIO's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: MBIO) Mustang Bio's current Earnings Per Share (EPS) is -$7.88. In 2025, MBIO's EPS is forecast to hit -$17.85 (min: -$17.15, max: -$18.38).
What is MBIO's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: MBIO) forecast ROE is -1,333.42%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.